Yeah, strange one. Good to see them use the debt facility to...

Yeah, strange one. Good to see them use the debt facility to ramp up Nirobox / Aspiral adoption. Happy to see all $50m of this used to build a river of recurring revenue in the years to come. Presumably the potable product from desal is at a premium to the non-potable effluent from Aspiral too, so is Nirobox the preferred way to leverage this facility? The guy from Generate Capital specifies desal, so maybe so. With widespread adoption beyond the $50m, this could see FLuence eventually become a distributed water utility in the Carribbean, South East Asia, Pacific, North Africa etc. I'm guessing the capex from these installations don't contribute to the US$44m sales target for SPS in 2019 though? Or do they?

On another note, it seems the newsflow is ramping up? Is it too much to hope that the big guns are now mostly set. Ron's got his mate Jay-the-rising-Republican-environmentalist on board, the CR allowed a few US insto mates in, and we're now ready to let the brakes off a little and push it to a higher valuation? Any speeding questions, point to the newsflow. I mean, we've already seen a small but significant re-rate in recent weeks, but are they still pushing? Where will it go in the short-term? I'm excited to find out, so I say keep the news flowing.